Licensing appeal | Veterinary relief | EV growth
A modestly valued company covered here has evident brand and licensing appeal, but it’s manufacturing operations continue to provide some challenges. Elsewhere, one of our Bonkers Bargains encouraged with news of another nice contract win, while there was relief for a veterinary group following a reasonable outcome to a CMA review. Read on here for our thoughts on this and other news, including an epic challenge being undertaken by Investor's Champion's Megan Boxall.
Volex: shares climb on positive update Volex (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, reassured with its half year trading update. For the 6 months to the end of September 2025 revenues are expected to exceed $575m with organic revenue growth for the period of at least 11% driven by strong growth from its Electric Vehicles, Off-Highway and Complex Industrial Technology segments. Operating profit margin for the first half is expected to remain within the upper half of the target range of 9-10%, however, that probably allows for plenty of adjustments. According to management,…